4th Quarter - Report
KITE PHARMA, INC. for KITE PHARMA, INC.
Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to CAR T; policy issues relating to Medicare inpatient and outpatient reimbursement, including the New Technology Add-on Payment program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA GRIFFIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.